Cardiac Na+/Ca2+ exchange stimulators among cardioprotective drugs
نویسندگان
چکیده
منابع مشابه
Why do we still not have cardioprotective drugs?
Despite thousands of publications describing agents that limit infarct size in animals, all we have available today is reperfusion therapy. In this review, we examine why these drugs have not been translated into clinical practice. Many of the first interventions tested in clinical trials were very controversial in animal trials and their actual efficacy is still in question. Interventions base...
متن کاملPrescription of cardioprotective drugs after acute kidney injury
Introduction It is estimated that 5% of critically ill patients with acute kidney injury (AKI) require renal replacement therapy (RRT). Increasing data suggests that they have an increased risk of progressive chronic kidney disease, cardiovascular morbidity and premature death. The exact reasons for these poor outcomes following AKI are incompletely understood. Discontinuation of cardioprotecti...
متن کاملInnate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program.
Ischemic preconditioning is thought to evoke cell survival programs in the heart in large part via the activation of G(I)-protein coupled receptor signal transduction pathways. However, the identification and characterization of G(I)-protein coupled receptor independent pathways would enable researchers to pursue novel cellular events that could direct or promote preconditioning. In this regard...
متن کاملnnate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program
Ischemic preconditioning is thought to evoke cell survival programs in the heart in large part via the activation of G -protein coupled I receptor signal transduction pathways. However, the identification and characterization of G -protein coupled receptor independent I pathways would enable researchers to pursue novel cellular events that could direct or promote preconditioning. In this regard...
متن کاملElectrical stimulation to optimize cardioprotective exosomes from cardiac stem cells.
Injured or ischemic cardiac tissue has limited intrinsic capacity for regeneration. While stem cell transplantation is a promising approach to stimulating cardiac repair, its success in humans has thus far been limited. Harnessing the therapeutic benefits of stem cells requires a better understanding of their mechanisms of action and methods to optimize their function. Cardiac stem cells (CSC) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Physiological Sciences
سال: 2019
ISSN: 1880-6546,1880-6562
DOI: 10.1007/s12576-019-00721-5